Earnings call Insmed delivered a standout Q2 2026, with BRINSUPRI revenue of $309.2M (up 49% QoQ), driving a full-year guidance raise to $1.25B-$1.4B. Management increased peak sales estimates for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results